O'Connell Mj
Impact in
-
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Lung Cancer Research Studies
- Colorectal Cancer Screening and Detection
- Cancer Treatment and Pharmacology
-
- Genetic factors in colorectal cancer
Papers in
- Oncology 19
- Cancer Treatment and Pharmacology 9
- Colorectal Cancer Treatments and Studies 5
-
- Biochemical and Molecular Research 4
- Cancer therapeutics and mechanisms 2
- Co-authors
- Beart Rw (1 shared paper)Moertel Cg (12 shared papers)Robert G. Hahn (9 shared papers)Joseph Rubin (1 shared paper)Eagan Rt (3 shared papers)Schutt Aj (8 shared papers)Edmonson Jh (6 shared papers)Joshua T. Rubin (4 shared papers)
- Journals
- PubMed (34 papers)
- Partner nations
- United States
In The Last Decade
O'Connell Mj
33 papers receiving 286 citations
Peers
Comparison fields: 5 of 61
- Oncology 195
- Pathology and Forensic Medicine 56
- Neurology 36
- Cancer Research 34
- Toxicology 7
Countries citing papers authored by O'Connell Mj
This map shows the geographic impact of O'Connell Mj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O'Connell Mj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O'Connell Mj more than expected).
Fields of papers citing papers by O'Connell Mj
This network shows the impact of papers produced by O'Connell Mj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O'Connell Mj. The network helps show where O'Connell Mj may publish in the future.
Co-authors
The 25 scholars most cited alongside O'Connell Mj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Postoperative follow-up of patients with carcinoma of the colon. | 1983 | 62 |
| 2 | Pharmacokinetics of mitomycin C in patients receiving the drug alone or in combination. | 1983 | 29 |
| 3 | Phase II study of cisplatin therapy in patients with metastatic carcinoid tumor and the malignant carcinoid syndrome. | 1986 | 29 |
| 4 | Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancer. | 1976 | 22 |
| 5 | High-dose cytosine arabinoside and mAMSA induction and consolidation in patients with previously untreated de novo acute nonlymphocytic leukemia: Phase I Pilot Study for the Eastern Cooperative Oncology Group. | 1985 | 15 |
| 6 | Phase I study of N-(phosphonacetyl)-L-aspartic acid (PALA). | 1980 | 14 |
| 7 | Phase II trial of maytansine in patients with advanced colorectal carcinoma. | 1978 | 10 |
| 8 | Evaluation of a fixed alternating treatment in patients with advanced breast cancer. | 1978 | 9 |
| 9 | Pancreatic cancer in the older patient. | 2001 | 9 |
| 10 | Is hepatic infusion of chemotherapy effective treatment for liver metastases? No! | 1992 | 9 |
| 11 | Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy. | 1978 | 8 |
| 12 | Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer. | 1987 | 8 |
| 13 | Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group study. | 1984 | 8 |
| 14 | Evaluation of vinblastine administered by 5-day continuous infusion in women with advanced breast cancer. | 1984 | 7 |
| 15 | Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma. | 1976 | 6 |
| 16 | Early clinical trial of a 1-day intermittent schedule for pentamethylmelamine. | 1981 | 6 |
| 17 | Randomized clinical trial comparing two dose regimens of ICRF-159 in refractory malignant lymphomas. | 1980 | 6 |
| 18 | Pilot study of two adriamycin-based regimens in patients with advanced malignant lymphomas. | 1977 | 6 |
| 19 | Lymphocytic lymphoma involving the middle ear. | 1980 | 6 |
| 20 | Phase II study of dianhydrogalactitol and ICRF-159 in patients with advanced breast cancer previously exposed to cytotoxic chemotherapy. | 1977 | 5 |
About O'Connell Mj
O'Connell Mj is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Neurology and Pathology and Forensic Medicine, having authored 34 papers that have together received 318 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (9 papers), Colorectal Cancer Treatments and Studies (5 papers), Biochemical and Molecular Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Cancer therapeutics and mechanisms (2 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (195 citations), Pathology and Forensic Medicine (56 citations), Neurology (36 citations), Cancer Research (34 citations) and Toxicology (7 citations). O'Connell Mj has collaborated with scholars based in United States. Frequent co-authors include Beart Rw, Moertel Cg, Robert G. Hahn, Joseph Rubin, Eagan Rt, Schutt Aj, Edmonson Jh, Joshua T. Rubin, Stephen Frytak and Kvols Lk. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.